Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2018BMJ OpenOpen Access

Healthcare professionals’ perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMohammed AladulUniversity of MosulRFR FitzpatrickKeele UniversitySCStephen ChapmanUniversity of Leeds

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aladul et al. (2018) studied this question.

synapsesocial.com/papers/6a6f7661e71d69abee08084ahttps://doi.org/10.1136/bmjopen-2018-023603
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patient Perspectives on Biosimilar Insulin2014 · 48 citations
  2. 2Using thematic analysis in psychology2006 · 194,936 citations
  3. 3What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences2017 · 5 citations
  4. 4Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization2014 · 103 citations
  5. 5Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians2016 · 209 citations